, Tracking Stock Market Picks
Enter Symbol:
Human Genome Sciences, Inc. (HGSI) [hlAlert]

up 136.31 %

Human Genome Sciences, Inc. (HGSI) rated Outperform by Bear Stearns

Posted on: Thursday,  Jan 24, 2008  8:25 AM ET by Bear Stearns

Bear Stearns rated Outperform Human Genome Sciences, Inc. (NASDAQ: HGSI) on 01/24/2008, when the stock price was $6.03.
Since then, Human Genome Sciences, Inc. has gained 136.32% as of 08/01/2012's recent price of $14.25.
If you would have followed this Bear Stearns's recommendation on HGSI, you would have gained 136.31% of your investment in 1651 days.

Human Genome Sciences is a biopharmaceutical company with a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Additional products are in clinical development by companies with which we are collaborating. Its mission is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody products.

The Bear Stearns Companies Inc. (NYSE: BSC) is the parent company of Bear, Stearns & Co. Inc., a leading global investment banking, securities trading and brokerage firm. Since 1923, we have helped corporations, institutions, governments and individuals reach their financial objectives. Clients have come to rely on the breadth of our expertise, our commitment to client service and our innovative approach to problem-solving. Talented professionals join Bear Stearns because of our unique corporate culture. Based on respect, integrity, meritocracy, innovation and a commitment to philanthropy, these guiding principles serve as blueprint for the way that we do business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -12.16 %
1 Month up  58.53 %
3 Months down  -35.96 %
1 YTD down  -38.67 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy